BriaCell Therapeutics Corp. (BCTX) Goodwill & Intangibles (2019 - 2026)

BriaCell Therapeutics has reported Goodwill & Intangibles for 8 years, with the latest figure at $173072.0 in Q2 2026.

• Quarterly Goodwill & Intangibles fell 8.11% year-over-year to $173072.0 in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $173072.0 (down 8.11% YoY) and the FY2025 annual result came in at $184525.0, down 7.64% from the prior year.
• Goodwill & Intangibles retreated to $173072.0 in Q2 2026 per BCTX's latest filing, from $176889.0 in the prior quarter.
• Over five years, Goodwill & Intangibles peaked at $305130.0 in Q3 2022 and troughed at $173072.0 in Q2 2026.
• A 5-year average of $209678.0 and a median of $205522.5 in 2024 frame the typical range for Goodwill & Intangibles.
• The sharpest annual moves came in 2022 and 2023: Goodwill & Intangibles changed 0.0% in 2022, then retreated 29.52% in 2023.
• Over 5 years, Goodwill & Intangibles stood at $226521.0 in 2022, then slipped by 6.74% to $211250.0 in 2023, then retreated by 7.23% to $195978.0 in 2024, then decreased by 7.79% to $180707.0 in 2025, then dropped by 4.23% to $173072.0 in 2026.
• According to Business Quant data, Goodwill & Intangibles over the past three periods registered $173072.0, $176889.0, and $180707.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.